To Study the Efficacy & Safety of Oral NA-921 (Bionetide) in Girls and Women with Rett Syndrome
Public ClinicalTrials.gov record NCT06849973. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Phase 2/ Phase 3 Study of NA-921 (Bionetide) for the Treatment of Girls and Women with Rett Syndrome
Study identification
- NCT ID
- NCT06849973
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Lead sponsor
- Biomed Industries, Inc.
- Industry
- Enrollment
- 187 participants
Conditions and interventions
Conditions
Interventions
- Drug: Bionetide Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 5 Years to 20 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 14, 2024
- Primary completion
- Nov 21, 2024
- Completion
- Jan 27, 2025
- Last update posted
- Feb 26, 2025
2024 – 2025
United States locations
- U.S. sites
- 12
- U.S. states
- 9
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Biomed Testing Facility # BIO-04-92093 | La Jolla | California | 92093 | — |
| Biomed Testing Facility # BIO-03-90095 | Los Angeles | California | 90095 | — |
| Biomed Testing Facility # BIO-02-95817 | Sacramento | California | 95817 | — |
| Biomed Testing Facility # BIO-01-94104 | San Francisco | California | 94104 | — |
| Biomed Testing Facility #BIO-05-80042 | Aurora | Colorado | 80042 | — |
| Biomed Testing Facility #BIO-06-60612 | Chicago | Illinois | 60612 | — |
| Maryland Locations Biomed Testing Facility #BIO-7-21205 | Baltimore | Maryland | 21205 | — |
| Biomed Testing Facility #BIO-8-02115 | Boston | Massachusetts | 02115 | — |
| Biomed Testing Facility #BIO-9-10467 | The Bronx | New York | 10467 | — |
| Biomed Testing Facility #BIO-10-44195 | Cleveland | Ohio | 44195 | — |
| Biomed Testing Facility #BIO-11-77030 | Houston | Texas | 77030 | — |
| Biomed Testing Facility #BIO-12-98105 | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06849973, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 26, 2025 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06849973 live on ClinicalTrials.gov.